Diana L. Simons

City Of Hope National Medical Center — United States

Medicine · Health Sciences

14h-index1.2kcitations61works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(47), Immunotherapy and Immune Responses(37), Cancer, Stress, Anesthesia, and Immune Response(23), Immune Cell Function and Interaction(11), Cytokine Signaling Pathways and Interactions(7)

Publications61 total

Abstract 5133: End-stage breast cancer metastases manifest as two subtypes with distinct dissemination patterns, proliferation/EMT signatures, and immune microenvironments
Cancer Research·2025· 1 cited
Supplementary Figure 14 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 3 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 15 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 4 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 8 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 5 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 4 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 1 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Table 2 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 16 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 17 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 1 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 12 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 7 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 3 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 18 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 6 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 13 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
Supplementary Figure 11 from Organ-Specific Immune Setpoints Underlie Divergent Immune Profiles across Metastatic Sites in Breast Cancer
2024Open Access
page 1 of 4Next →

Frequent Co-authors

Peter P. Lee(49), Colt A. Egelston(35), James Waisman(34), Weihua Guo(28), Christian Avalos(27), Shawn T. Solomon(25), Daniel Schmolze(25), Jiayi Tan(25), Eliza R. Bacon(24), Kena Ihle(24), Lusine Tumyan(22), Michael S. Nelson(21), Jian Ye(20), Mary Nwangwu(19), John H. Yim(10), Frederick M. Dirbas(8), Andrea K. Miyahira(6), Travis Y. Tu(5), Yinghui Huang(5), Andrew Y. Chang(5)